The in vitro activity of BL-S640, a 7-(2-aryl-2-aminoacetamido)-3-(heterocyclic-thiomethyl) cephalosporin, was evaluated against 338 clinical isolates of Enterobacteriaceae in comparison with ampicillin, cephalothin, cefazolin, and cephalexin. Against Escherichia coli, BL-S640 was as active as cefazolin and more active than ampicillin, cephalothin, and cephalexin. BL-S640 was as effective as the other cephalosporins tested and far more active than ampicillin against Klebsiella and was more active than cephalexin against Proteus mirabilis and the indole-positive Proteus. The majority of Enterobacter, Serratia, and Citrobacter were resistant to ampicillin and all the cephalosporins tested. With rare exceptions, the zone of inhibition by the BL-S640 30-jgg disk was either larger or the same as the zone obtained by the cephalothin 30-,ug disk in the Kirby-Bauer disk susceptibility test.
BL-S640 is a 7-(2-aryl-2-aminoacetamido)-3-(heterocyclic-thiomethyl) cephalosporin. Preliminary studies conducted at the Bristol Laboratories revealed that BL-S640 has a broad antimicrobial spectrum and that it was well absorbed by the mouse after parental or oral administration (F. Leitner, R. E. Buck, M. Misiek, T. A. Pursiano, D. R. Chisholm, Y. H. Tsai, G. E. Wright, and K. E. Price, Prog. Abstr. Intersci. Conf. Antimicrob. Ag. Chemother., 14th, San Francisco, Calif., Abstr. 421, 1974) . BL-S640 was also well absorbed after oral administration to human volunteers resulting in significant plasma and urinary concentration (M. Pfeffer, D. L. Hudson, and D. R. Van Harken, Prog. Abstr. Intersci. Conf. Antimicrob. Agents Chemother., 14th, San Francisco, Calif., Abstr. 422, 1974 (6) .
The correlation of the MIC of BL-S640 as determined by the agar dilution method and the zone of inhibition by a 30-jig BL-S640 disk is shown in Fig. 1 To determine whether the 30-,ug cephalothin disk is suitable to be used for separating organisms susceptible to BL-S640 from resistant organisms, the MIC of BL-S640, as determined by the agar dilution method, was plotted against the zone of inhibition by a 30-,g cephalothin disk (Fig. 2) . If the same criteria (MIC of 8 gg/ml or less and 18 mm or more) were used as criteria indicating susceptibility, 12.4% of the isolates would be considered falsely resistant whereas a 6.2% would be considered falsely, susceptible by the cephalothin disk (30 ,ug) susceptibility test. In Fig. 3 , the zone of inhibition by a 30-Ag BL-S640 disk was plotted against the zone of inhibition by a 30-,gg cephalothin disk. With rare exception, the zone of inhibition by the BL-S640 disk was either larger or the same as the zone obtained by the cephalothin disk. Seneca (5) also reported differences in zones of inhibition obtained with different cephalosporin disks and he advocated the use of different cephalosporin disks for routine clinical testing. However, he did not determine MIC values. In the case of BL-S640, it appears that the cephalothin disk is as good if not better than the BL-S640 disk in separating the susceptible from the resistant organisms since there were less false susceptibles when the cephalothin disk was used.
The comparative in vitro susceptibility of 338 Table 1 . Against E. coli, BL-S640 was more active than cephalexin BL-S640 was as active as cefazolin and more against these organisms. The majority of Enteractive than ampicillin, cephalothin, and ceph-obacter, Serratia, and Citrobacter were resistalexin. BL-S640 was as effective as the other ant to ampicillin and the cephalosporins tested cephalosporins tested and far more active than including BL-S640. Inoculum effect. One hundred selected isolates with a wide range of in vitro susceptibility were used to study the inoculum effect on the in vitro susceptibility to BL-S640. These included 40 isolates of E. coli; 20 isolates each of Klebsiella sp. and P. mirabilis; and 10 isolates each of Enterobacter sp. and indole-positive Proteus sp. The MIC and minimal bactericidal concentration of BL-S640 were determined by a broth dilution method using Mueller Hinton broth (2) . Two inoculum sizes (10-i and 10' dilutions of an overnight culture) were used. The results are depicted in Fig. 4 . The MIC and minimal bactericidal concentrations were either the same or only one to two dilutions different. There was also an inoculum effect, perhaps more pronounced with Enterobacter and indolepositive Proteus which were the more resistant organisms. As for the more susceptible organisms, such as Klebsiella and E. coli, the inoculum effect was much less and in the case of P. mirabilis it was minimal.
Until the recent approval of cephradine (4), cephalexin (3) was the only oral cephalosporin available for the therapy of systemic infections. The development of newer oral cephalosporins with better microbiologic and pharmacologic qualities is indicated. Results of the present investigation indicate that, in general, BL-S640 was more active than cephalexin in vitro against Enterobacteriaceae. However, a high percentage of Enterobacter, Serratia, and Citrobacter were resistant to BL-S640 as well as other cephalosporins tested. In view of its significant in vitro activity, BL-S640 appears to be a promising semisynthetic oral cephalosporin. Further pharmacologic and toxicologic studies are warranted.
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